Collegium Announces Positive Topline Results for Hydrocodone DETERx® Clinical Study by Seini Moimoi | Jun 22, 2016 | Portfolio News
Aimmune Therapeutics Appoints Daniel Adelman, M.D., as Chief Medical Officer by Seini Moimoi | Jun 21, 2016 | Portfolio News
Orbus Therapeutics Granted Orphan Drug Designation by European Medicines Agency for Late-Stage Brain Cancer Drug by Seini Moimoi | Jun 17, 2016 | Portfolio News
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors by mariel | Jun 13, 2016 | Portfolio News